About Nidhi Agarwal

Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.

Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.


Recent Articles By Nidhi Agarwal

: FUJHY |  News, Ratings, and Charts

Analyzing Buy, Hold, or Sell For These 3 Auto Picks

The auto industry is expected to flourish due to technological advancements and the rising adoption of electric vehicles. While the industry outlook may seem promising, let us analyze whether to Buy, Hold or Sell auto stocks, Subaru (FUJHY), Harley-Davidson (HOG), and Workhorse Group (WKHS)...
: ACN |  News, Ratings, and Charts

3 Lucrative Tech Stocks Set for 2024 Success

The tech industry’s growth prospects look promising thanks to the increasing adoption of cloud computing and digitization. Amid increasing tech reliance, it could be wise to buy fundamentally strong tech stocks, Accenture (ACN), Spirent Communications (SPMYY), and RADCOM (RDCM) for 2024 success. Keep reading...
: LI |  News, Ratings, and Charts

Should Investors Buy Into These 3 Popular EV Stocks?

The electric vehicle (EV) industry is expanding amid concerns about climate change and tech advancements. Therefore, let’s analyze whether to buy popular EV stocks Li Auto (LI), Tesla (TSLA) and Nikola (NKLA)...
: HWKN |  News, Ratings, and Charts

3 Underrated Chemical Stocks With Buying Potential

The chemical industry’s growth prospects look promising thanks to the growing demand across various sectors and the integration of technology. Therefore, it could be wise to buy fundamentally strong chemical stocks Hawkins (HWKN), Orion (OEC), and Oil-Dri Corporation of America (ODC). Read more...
: ZTS |  News, Ratings, and Charts

3 Growth Pharma Stocks to Guard Your Portfolio

The pharma industry is experiencing significant growth, fueled by rising demand for personalized medicines, a revolutionary wave of drug development and robust government support. Therefore, it could be wise to consider fundamentally strong pharma stocks Zoetis (ZTS), Bristol-Myers Squibb (BMY), and Teva Pharmaceutical Industries (TEVA) to guard your portfolio. Read more...
: HON |  News, Ratings, and Charts

General Electric (GE) vs. Honeywell International (HON) - 2024 Market Insights

The industrial sector’s prospects look attractive due to rising demand for automation of production processes and specialized industrial services. Industrial stocks, General Electric (GE) and Honeywell International (HON), are well-positioned to benefit from the industry tailwinds. However, which of these is the better buy? Read more to find out...
: HTHIY |  News, Ratings, and Charts

Plug Power (PLUG) vs. Hitachi (HTHIY): Which Industrial Stock is Among Investor Picks

The industrial sector is set to continue its momentum this year due to rising industrial activities and the integration of advanced technologies. While leading industrial stocks Plug Power (PLUG) and Hitachi (HTHIY) should benefit from the industry tailwinds, let us predict the right pick...
: TTMI |  News, Ratings, and Charts

3 Tech Stocks Bursting With Opportunities This Week

The technology industry is positioned for long-term growth due to the rapid adoption of new and emerging technologies across industries. Moreover, given consistent advancements, tech stocks, TTM Technologies (TTMI), PC Connection (CNXN), and Ceragon Networks (CRNT) might be worth buying. Read more...
: PEGA |  News, Ratings, and Charts

3 Software Stocks to Buy for Positive Investments

The software industry’s growth prospects look promising thanks to the increasing adoption of cloud computing and customized software. Therefore, it could be wise to buy fundamentally strong software stocks, Pegasystems (PEGA), EverCommerce (EVCM), and Karooooo (KARO) for positive investments. Keep reading...
: PLX |  News, Ratings, and Charts

Biotech Stock Success: Top 3 Picks for Monthly Gains

Amid the dynamic biotech landscape, the sector is set to witness an upward trajectory fueled by consistent advancements. Therefore, it could be wise to buy fundamentally strong biotech stocks Protalix BioTherapeutics (PLX), Organogenesis Holdings (ORGO), and ANI Pharmaceuticals (ANIP) for monthly gains. Read more...
Page generated in 0.964 seconds.